AMEC: the capital increase and acquisition of part of the equity of hoons biopharma in South Korea have been completed
Financial Associated Press, October 22 (Xinhua) - aimeike announced that recently, aimeike received information about the equity transfer and capital increase of South Korea's hoons bio. According to the investment agreement, the company needs to pay 155.395 billion won, and the trading company paid a total of 856 million yuan for equity investment. The source of funds is some over raised funds of the company. The transaction makes rational use of funds and does not affect the normal development of the company's main business.
This text is a result of machine translation.
Related companies：
In-depth
Briefing Jun 27, 2022 01:05 PM
Putin will soon visit Central Asia and attend the Caspian summit, which is the first visit since the conflict between Russia and Ukraine
Briefing Jun 20, 2022 10:44 PM
· Consumer Staples
China Evergrande: it is expected to announce the preliminary restructuring plan at the end of July
May 11, 2023 05:07 PM
Dec 14, 2020 08:20 PM
Research
Consumer Staples, Technology, AutomotiveTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Consumer Discretionary, Consumer Staples, HealthcareLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Briefing May 23, 2022 02:13 PM
· Technology
Evergrande real estate was enforced for another 4.183 billion yuan
Briefing May 23, 2022 12:38 PM
· Healthcare
Aimeike signs distribution cooperation framework agreement with South Korea huons BP
Briefing Apr 26, 2022 04:15 PM
· Healthcare
Luoxin pharmaceutical: delayed disclosure of the first quarter report of 2022
Briefing Apr 25, 2022 03:15 PM
The central bank convened a meeting between financial institutions and 12 real estate enterprises, involving the rescue of M & a business
Briefing Mar 14, 2022 04:59 PM
· Healthcare
Guangdong: promote the pilot settlement of digital RMB in Guangzhou
See more
Read next
Insight
In-depth
Insight
In-depth
Embodied AI · Analysis
The Real Bottleneck in Embodied AI: Not Just AI, but Scenarios
Yesterday 09:34 AM
Insight
In-depth
Embodied AI · Analysis
Investment Is Booming, Orders Are Rising, but Robots Are Still Learning How to Deliver
Mar 23, 2026 10:29 AM
Insight
In-depth
Automotive · Analysis
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM